These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19817936)

  • 21. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
    Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
    Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of Antihypertensive Therapy in Patients Older Than 80 Years: Cohort Study and Markov Model.
    Hazra NC; Rudisill C; Jackson SH; Gulliford MC
    Value Health; 2019 Dec; 22(12):1362-1369. PubMed ID: 31806192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
    Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
    JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Pharmacoeconomics; 2009; 27(3):221-30. PubMed ID: 19354342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value-based approach to blood pressure telemonitoring and remote counseling in hypertensive patients.
    Ionov MV; Zhukova OV; Yudina YS; Avdonina NG; Emelyanov IV; Kurapeev DI; Zvartau NE; Konradi AO
    Blood Press; 2021 Feb; 30(1):20-30. PubMed ID: 32954832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).
    Penaloza-Ramos MC; Jowett S; Mant J; Schwartz C; Bray EP; Sayeed Haque M; Richard Hobbs FD; Little P; Bryan S; Williams B; McManus RJ
    Eur J Prev Cardiol; 2016 Jun; 23(9):902-12. PubMed ID: 26603745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK.
    Gladwell D; Henry T; Cook M; Akehurst R
    Appl Health Econ Health Policy; 2014 Dec; 12(6):611-22. PubMed ID: 25086585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY; Feugier P; Workineh S; Harbaoui B; Bricca G; Lantelme P
    Arch Cardiovasc Dis; 2014 Dec; 107(12):690-6. PubMed ID: 25445751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of transcarotid artery revascularization versus carotid endarterectomy.
    Cui C; Ramakrishnan G; Murphy J; Malas MB
    J Vasc Surg; 2021 Dec; 74(6):1910-1918.e3. PubMed ID: 34182030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.
    Montgomery AA; Fahey T; Ben-Shlomo Y; Harding J
    J Hypertens; 2003 Sep; 21(9):1753-9. PubMed ID: 12923409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T; Scheffers I; De Leeuw PW; Winkens B; Jongen-Vancraybex H; Tordoir JH; Schmidli J; Mohaupt MG; Allemann Y; Kroon AA
    J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL; Nadim MK; Haller H; Lovett EG; Schafer JE; Bisognano JD
    J Am Soc Hypertens; 2012; 6(2):152-8. PubMed ID: 22341199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.
    Vasudeva E; Moise N; Huang C; Mason A; Penko J; Goldman L; Coxson PG; Bibbins-Domingo K; Moran AE
    Am J Hypertens; 2016 Oct; 29(10):1195-205. PubMed ID: 27172970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of impedance cardiography testing in uncontrolled hypertension.
    Ferrario CM; Smith RD;
    Am Heart Hosp J; 2006; 4(4):279-89. PubMed ID: 17086009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
    Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Bryant KB; Moran AE; Kazi DS; Zhang Y; Penko J; Ruiz-Negrón N; Coxson P; Blyler CA; Lynch K; Cohen LP; Tajeu GS; Fontil V; Moy NB; Ebinger JE; Rader F; Bibbins-Domingo K; Bellows BK
    Circulation; 2021 Jun; 143(24):2384-2394. PubMed ID: 33855861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.
    Fonarow GC; Keech AC; Pedersen TR; Giugliano RP; Sever PS; Lindgren P; van Hout B; Villa G; Qian Y; Somaratne R; Sabatine MS
    JAMA Cardiol; 2017 Oct; 2(10):1069-1078. PubMed ID: 28832867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.